论文部分内容阅读
目的观察伊布利特与普洛帕酮治疗室上性心动过速患者的临床疗效。方法将本院收治的120例室上性心动过速患者随机分为伊布利特组和普洛帕酮组各60例,分别给予静脉注射伊布利特和普洛帕酮治疗。观察两组治疗总有效率、平均转复时间及副作用情况。结果伊布利特组治疗总有效率为96.7%,普洛帕酮组为85.0%,伊布利特组平均转复时间明显短于普洛帕酮组,且伊布利特组副作用明显少于普洛帕酮组,两组对比差异明显。结论伊布利特与普洛帕酮比较,具有疗效好、转复时间短、不良反应少等优点。
Objective To observe the clinical efficacy of ibutilide and plo- laprenone in the treatment of patients with supraventricular tachycardia. Methods A total of 120 patients with supraventricular tachycardia admitted to our hospital were randomly divided into two groups: ibutilide group and ploperipirone group. Each group received intravenous injection of ibutilide and propafenone. The total effective rate, average recovery time and side effects of the two groups were observed. Results The total effective rate of the ibutilide group was 96.7%, that of the propafenone group was 85.0%, the average recovery time of the ibutilide group was shorter than that of the ploperimental group, and the side effects of the ibutilide group were less In the plo- lapone group, there was significant difference between the two groups. Conclusion Ibutilide and pachloroprazet have the advantages of good curative effect, short recovery time and few adverse reactions.